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 Variability of lung nodule classification in submillisievert CT was assessed 
 Overall interobserver agreement between all readers was moderate (k = 0.454) 
 Major reason for disagreement on nodule classification was lesion measurement  
 Lung cancer screening with submillisievert CT needs careful standardisation 
 
Abstract 
Purpose: To assess the interreader variability of submillisievert CT for lung cancer 
screening in radiologists with various experience levels.  
Method: Six radiologists with different degrees of clinical experience in radiology 
(range, 1-15 years), rated 100 submillisievert CT chest studies as either negative 
screening finding (no nodules, benign nodules, nodules <5 mm), indeterminate finding 
(nodules 5-10 mm), positive finding (nodules >10 mm). Each radiologist interpreted 
scans randomly ordered and reading time was recorded. Interobserver agreement was 










analysed on a case-by-case basis. Reading time was correlated with reader 
experience using Pearson correlation (r). 
Results: The overall interobserver agreement between all readers was moderate 
(k=0.454; p<0.001). In 57 patients, all radiologists agreed on the differentiation of 
negative and indeterminate/positive finding. In 64 cases disagreement between 
readers led to different nodule classification. In 8 cases some readers rated the nodule 
as benign, whereas others scored the case as positive. Overall, disagreement in 
nodule classification was mostly due to failure in identification of target lesion (n=40), 
different lesion measurement (n=44) or different classification (n=26). Mean overall 
reading time per scan was of 2 min 2 s (range: 7s-7min 45s) and correlated with reader-
experience (r =-0.824). 
Conclusions: Our study showed substantial interobserver variability for the detection 
and classification of pulmonary nodules in submillisievert CT. This highlights the 
importance for careful standardisation of screening programs with the objective of 
harmonizing efforts of involved radiologists across different institutions by defining and 
assuring quality standards. 
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1. INTRODUCTION 
Lung cancer is the leading cause of cancer deaths in Europe and around the 
world [1]. Over 50% of newly diagnosed lung cancer patients are former, not current, 
smokers [2] and the combination of poor outlook, lag time and large population “at risk” 










[3]. As the population at risk is relatively well defined and early stage disease is 
potentially curable, lung cancer outcomes may be improved by screening. The main 
target of lung cancer screening programs with computed tomography (CT) is an early 
detection and treatment of potentially malignant pulmonary lesions to improve clinical 
outcomes, as relative survival rates without recurrence of non-small cell lung cancer is 
up to 80% when detected at a locally confined stage [4; 5]. With positive results from 
the National Lung Screening Trial (NLST) that suggested a reduced lung cancer 
mortality among people at high risk [6] the interest in screening increased over the past 
decade. Large multicentre studies in Europe such as the Dutch-Belgian randomised 
lung cancer multi-slice CT screening trial (NELSON) also reported favourable results 
but are currently ongoing [7; 8], yet different societies already recommend lung cancer 
screening [9; 10].  
In every lung cancer screening program, subjects undergo multiple screening 
rounds within a certain time period and in order to keep the cumulative radiation 
exposure reasonable, so-called “low dose” CT protocols are established. Various 
technical innovations (e.g., tin filtration, iterative image reconstruction) in the past years 
allowed for a steady and even bigger reduction of applied radiation dose beyond 
standard “low dose” protocols, permitting submillisievert lung CT at the dose of a two-
view chest X-ray examination [11]. Recent studies have already reported a high 
diagnostic accuracy of this technique for the detection and assessment of different 
pathologies in the lung, mainly focussing on pulmonary nodule detection [11-13]. 
Beyond sole detection, the correct classification of CT screening studies as 
either negative (i.e., no or only benign nodules present) or positive (i.e., pulmonary 
nodules present) among different radiologists is crucial for an effective screening 
programme and has a major effect on patient management. Reproducible and 










desired and has to be guaranteed, especially when extremely lowering the utilized 
radiation dose levels. 
Accordingly, the aim of our study was to assess interreader agreement of chest 
X-ray-equivalent dose CT for lung cancer screening in radiologists with various levels 











2. MATERIALS AND METHODS 
2.1. Overview and study design 
The patients included in this study are part of a prospective study at our 
institution on reduced radiation dose CT (clinicaltrials.gov Identifier *blinded for 
review*). This is an investigator-initiated study and no funding was received by any 
funding agencies in the public, commercial, or not-for-profit sectors. The institutional 
ethics committee approved the study. All patients included in this study gave written 
informed consent for a CT with submillisievert dose additionally to a clinically indicated 
standard dose CT. The study was conducted in compliance with ICH-GCP-rules and 
the declaration of Helsinki. 
2.2. Patients 
One hundred patients that were referred to our division for a clinically indicated 
CT between February and June 2015 were prospectively included in the study and 
scanned with an additional submillisievert CT of the chest in the same session. 
Inclusion criteria were a clinically indicated chest CT with or without contrast media for 
various indications (e.g., follow up of pulmonary nodule, suspicion of pulmonary 
embolism, work up of suspicious lesion in chest X-ray). Exclusion criteria for being 
included in the study was (a) pregnancy and/or (b) age < 18 years. The study group 
has been partly shared and is described more in detail in a previous publication [14].  
2.3. Reduced dose (submillisievert) CT protocol 
All scans were performed using a third-generation dual-source 192 section CT 
scanner (SOMATOM Force; Siemens Healthineers, Forchheim Germany) [15]. 
Patients were scanned according a CT protocol that was previously described in detail 
[14]. A similar scan protocol assessing pulmonary nodule detection rate was used in a 










Dose-length-product (DLP) and volume CT dose index CTDIvol were retrieved 
from the electronically logged patient protocol. The effective radiation dose was then 
calculated by multiplying the DLP with the conversion coefficient k of 0.014 
mSv/mGycm [16]. We further assessed the effective diameters of the chest for each 
subject and calculated the size-specific dose estimates (SSDE) applying the size-
specific conversion factor fsize from the AAPM Report 204 (SSDE = fsize × CDTIvol) [17]. 
2.4. Data reconstruction 
CT images were reconstructed with advanced modelled iterative reconstruction 
(ADMIRE; Siemens Healthineers) as described in detail before [11] at a strength level 
of 3 using a slice thickness of 2 mm with an increment of 1.6 mm and an edge-
enhancing convolution kernel (Br64). The reconstructed field-of-view (FoV) was in 
general 400 mm and in patients with a body-mass-index of >30 kg/m2 480 mm. The 
image matrix size was 512 x 512 pixels. Image analyses were performed on a picture 
archiving and communication system workstation using Impax EE (Version R20 XV 
SU2; Agfa Healthcare N.V., Mortsel, Belgium) and a standard high-definition liquid 
crystal display monitor for clinical reporting (BARCO; Medical Imaging Systems, 
Kortrijk, Belgium). 
2.5. CT data analysis 
Submillisievert CT studies of 100 patients were assigned to the readers in 
random orders with a random number generator 
(http://stattrek.com/Tables/Random.aspx). Radiologists completed an evaluation 
spread sheet assessing CT series (lung window CT setting; window level of -600 HU 
and a width of 1200 HU) for the presence of pulmonary nodules. As pulmonary nodules 
the readers classified circumscribed opacities in the pulmonary interstitium with 










Subpleural nodules and nodules along the fissures were not included. Readers did not 
differ between solid, part-solid or subsolid nodules. 
 If a nodule was present, they had to measure axial nodule diameter (i.e., 
longest diameter) and to classify studies as follows: 1) no nodule present (N1); clearly 
benign nodule containing calcification (N2/C); clearly benign nodule containing fat 
(N2/F); any other nodule < 5 mm (N3); nodules between 5 – 10 mm (I); nodules > 10 
mm (P). These findings were further subdivided in “negative findings” (N1, N2/C, N2/F, 
N3) where no further action is needed and indeterminate findings (I) as well as positive 
findings (P) were further work up is required, according Table 1 and Figure 1. If 
multiple pulmonary nodules were present, the most suspicious nodule was defined as 
“target lesion” and used as guide for management according to the guidelines of the 
Fleischner Society [19]. Readers were allowed to change window settings and to 
magnify images at will. They were blinded to the other radiologists’ findings. The time 
it took for the complete evaluation of the study was recorded. The rationale for 
choosing the aforementioned somewhat simplified “nodule classification” system was 
as follows: Currently, neither in our department nor in any institution in our country a 
lung cancer screening is performed, which is why the radiologists are not familiar with 
any lung cancer screening guideline (e.g., American College of Radiology, ACR; nor 
British Thoracic Society, BTS). A table linking our classification system to the 
ACR/Lung-RADS system (source: https://www.acr.org/Clinical-Resources/Reporting-
and-Data-Systems/Lung-Rads) can be found in Figure 2. 
2.7. Statistical analysis 
Continuous variables are expressed as mean ± SD, and categorical variables 
are expressed as frequencies or percentages. Cohen’s Kappa (k) was used to assess 










qualitatively as follows: slight agreement, 0.01–0.20; fair agreement, 0.21–0.40; 
moderate agreement, 0.41–0.60; substantial agreement, 0.61–0.80; excellent 
agreement, 0.81–0.99 [20]. The absolute number of agreements/disagreement was 
calculated considering also different classifications per case. Further, reading time was 
correlated to reading experience using Pearson-correlation (r). All statistical analyses 
were conducted using commercially available software (SPSS, release 22.0; SPSS, 












One hundred patients (36 female; median age 63 years; range 18 - 79 years) 
were included in the study and scanned with a submillisievert CT of the chest. 
3.1. Radiation dose values of the study protocol 
The median effective radiation dose of was 0.13 mSv (range, 0.11 – 0.16 mSv). 
The median DLP was 9.5 mGy-cm (range, 7.5 – 11.6 mGy-cm) and CTDIvol was 0.24 
mGy. The median effective diameter was 30 cm (range, 22 – 39 cm) and the median 
SSDE was 0.30 mGy (range, 0.21 – 0.40 mGy).  
3.2. Interobserver agreement 
The overall interobserver agreement between all readers was moderate (k = 
0.454; p < 0.001). When evaluating interobserver agreement between experienced 
readers, agreement levels were lower (k = 0.404, p < 0.001) compared to their younger 
colleagues (k = 0.544; p < 0.001). For interreader agreement in nodule classification, 
please refer to Table 2. Nodule classification per reader is presented in Table 3 and 
Figure 3. 
3.3. Positive/indeterminate vs. negative screening results 
Overall, in the differentiation of positive/indeterminate finding (i.e., further work-
up needed) and negative (i.e., no further action required) in 21 patients all radiologists 
agreed that the findings are indeterminate or positive and need further work-up and in 
36 patients all radiologists agreed that the patient has a negative CT scan, Figure 4. 
In the 22 cases where at least one reader rated the scan as positive (P) not all 
readers agreed and rated the scan as either indeterminate or negative: In 13 (59%) 










at least one reader who rated the scan as negative (i.e., N1-3) and in 8 (36%) cases 
at least one reader rated that there was no nodule present (i.e., N1), see Figure 4A. 
 In 43 cases where at least one reader rated the scan as positive (P) or 
indeterminate (I), meaning that the patient needs further work-up, not all readers 
agreed and assigned the scan as negative (i.e., N1-3): In 37 (86%) cases other readers 
assigned the scan as benign (i.e., N2) and in 21 (49%) cases at least one reader rated 
that there was no nodule present (i.e., N1), see Figure 4B. 
There was substantial variation in the total number of nodules recorded, with 
some readers identifying more than twice as many patients that have a nodule than 
others: In 45 patients at least one reader assigned “no pulmonary nodule found” (i.e., 
N1) even though other readers detected nodules. In these cases, 40 (89%) scans of 
the detected nodules were rated as negative (i.e., only benign and/or nodules < 5 mm; 
N2-3) by the other readers and in 21 (47%) cases at least one reader rated the findings 
as indeterminate (n = 16; 36%) or positive (n = 8; 18%) (Figure 4).  
3.4. Lesion size agreement 
In 23 cases variation of nodule measurements lead to different nodule 
classification. In 10 cases different nodule measurement and resulting different 
classification (B vs. I or P) affected patient work-up. The higher the nodule diameter, 
the higher were measurement differences among the readers resulting in a higher 
standard deviation and higher mean range of measurements, Table 4. 
3.5. Reasons for disagreement among readers 
A differentiated case-by-case evaluation of ratings of the different readers 
showed that the misclassification of the nodules was mostly due to failure of 
identification of the target lesion (n = 40), especially in cases where the disagreement 










accounted for n = 44 misclassified cases and affected especially the discrimination of 
benign from indeterminate findings. Another frequent pitfall was failure of detection of 
calcium (n = 24) or fat (n = 2). Another common reason for CT mis-classification were 
missed nodules: Overall, in 29% of cases reason for different CT classification were 
missed nodules – in 27% of cases missed nodules led to different patient management, 
Table 5 and Figure 5. The number of missed lesions did not significantly differ between 
experienced and unexperienced radiologists and no specific location (lung lobe) was 
identified where nodules were missed more often (p > 0.05). 
3.6. Reading time 
 Mean overall reading time was 2 minutes and 2 seconds per scan, whereas 
minimal reading time was 7 seconds and maximum time was 7 minutes and 45 
seconds.  
The three more experienced radiologists were significantly faster in reading CT 
scans compared to the three less experienced radiologists (mean 1 minute, range 7 
seconds to 2 minutes 39 seconds vs. mean 3 minutes 3 seconds, range 14 seconds 
to 7 minutes 45 seconds; p < 0.001). Mean overall reading time per scan correlated 













In our study we sought to assess the interreader agreement of chest X-ray dose-
equivalent (submillisievert) CT for correct nodule detection and classification and to 
identify and report potential pitfalls of pulmonary findings among radiologists with 
various levels of experience. While previous studies mainly focussed on nodule 
detectability [12; 13], this is, to our knowledge the first study to assess interreader 
agreement of pulmonary findings at such a low (submillisievert) radiation dose.  
Recently, multiple lung cancer screening studies using CT are ongoing in 
different countries [21; 22]. The National Lung Screening Trial in the United States [21] 
and the NELSON Trial in Holland/Belgium [8] have both presented encouraging 
results. In order to guarantee a high-quality expert chest CT report, an evaluation of 
the eventual pitfalls in screening CT by radiologists and education is needed.  
Our results indicate that there is a substantial interobserver variability for the 
detection and classification of pulmonary nodules, which may have impact on patient 
management. 
The study showed that in more than 40% of patients at least one radiologist did 
not agree with the reading of the others. This was partly due to a high interreader 
variability in the sub-classification of benign lesions and the notable number of benign 
lesions, which were not detected by a group of readers. The risk for malignancy in 
small nodules with a diameter of < 5 mm is very low with less than 1% [23]. This is also 
reflected in the 2015 published guidelines for the investigation and management of 
pulmonary nodules from the BTS [24], in which no nodule follow-up for people with 
nodules < 5 mm in maximum diameter is recommended. Similarly, the Fleischner 
Society states that in patients which are eligible for lung cancer screening (i.e., so 
called high risk patients such as smokers) nodules < 6 mm do not require routine follow 










therefore be ignored since they do not have impact on patient management. Similar to 
Gierada et al. [25] we observed a higher agreement for classification of cases as 
positive or indeterminate findings than of negative (i.e., benign) lesions.  
Nevertheless, there was also a substantial interreader variability in the 
classification of positive (P) and potential malignant lesions; > 10 mm, and 
indeterminate (I) lesions which may urge follow-up or initiation of further workup and 
may therefore have impact on patient management (e.g., by a delay of diagnosis or by 
unnecessary invasive work-up). 
Failure in nodule classification is not a new finding and was already reported by 
other authors [25-27]. For example, Ridge et al. [26] reported a high interreader 
variability in the differentiation of solid and subsolid pulmonary nodules (i.e., nodule 
classification). Gierada et al. [25] evaluated agreement among radiologists on the 
interpretation of pulmonary findings in screening examination for lung cancer and 
reported only a moderate to substantial interobserver agreement (k = 0.58) 
contemplating a potential for considerable improvement. Similar to our findings this 
study reported a wide range in the total number of lesions detected with some 
radiologists identifying several times as many non-calcified nodules than others [25]. 
In our study, relevant interreader differences were mainly due to variation of the 
identified target lesion, differences in classification of target lesions, discrimination 
between indeterminate (I) and positive lesions (P) especially in borderline sizes; the 
latter mainly due to variation of nodule measurements. An additional pitfall was that 
small lesions were often overlooked, however as already stated before small/benign 
lesions do not have to be followed-up and therefore the missed finding potentially does 
not have any impact in further patient management. Interestingly, the number of 











With regard to a screening setting, this highlights the importance for a rigorous 
training of involved radiologists and underlines the need for quality assurance systems 
with sufficient quality control mechanisms to provide high diagnostic accuracy for the 
screened population. Further, regular multidisciplinary review meetings should be held 
to discuss cases and decide on management as it is already recommended for breast 
cancer screening by the European Breast Cancer Network (EBCN) [28]. This may 
prove beneficial for feedback purposes of involved radiologists as well as for providing 
an optimized mechanism for refining individual case management decisions. Later in 
the course of a screening, the review of interval cancers by involved readers, as part 
of an organised process may also serve as an excellent feedback and educational 
mechanism [28]. As with regard to lung cancer screening, the ACR issued a quality 
assurance tool designed to standardize screening CT reporting and management 
recommendations, in order to reduce confusion in lung cancer screening imaging 
interpretations, and to facilitate outcome monitoring (i.e., so called Lung-RADS 
reporting system). Since we used slightly different size threshold cut-offs in our study 
no direct transformation of our findings is possible to centres using ACR or BTS 
guidelines. We have therefore amended our readout spreadsheet as supplementary 
material allowing individual assessment of respective variation relevant for different 
institutions. 
As stated before, differences in lesion measurement substantially contributed to 
disagreement among the readers. Variance in lesion measurement was a major cause 
of nodule mis-classification (28% overall – and 30% in cases were different 
measurement let to different patient management). This goes in line with earlier studies 
[29; 30], which have shown considerable variation in two-dimensional lung nodule size 










impact on patient management and thus the measurement issue should be addressed 
in the near future e.g. by automated volume measurement. 
Screening results and subsequent actions taken depend lastly on the sensitivity 
and interpretation skills of the radiologist. With some lesions, classification of screening 
findings as positive or negative is not a straightforward task and may depend on 
individual judgement and experience of the radiologist [25]. Interestingly, we observed 
an even lower interreader agreement among the experienced readers (k = 0.404) as 
compared to their less experienced colleagues (k = 0.544). 
Aside the training of radiologist, development of evidence-based nodule 
characterization criteria [32] and automated nodule characterization algorithms  [33] 
(e.g., including texture analysis) may also help increase agreement in nodule 
classification.  
With regard to radiation dose, the “low dose” protocol used in the NLST had a 
mean dose of 1.5 mSv per scan [6], being substantially higher compared to 0.13 mSv 
achieved in our study. There has, however, been some debate about how CT-related 
radiation dose values should be reported [34]. Bankier et al. argued that terms like “low 
dose” and “ultralow dose” are substantially limited by their relativistic foundation, and 
therefore recommended not to use them. We have therefore used a more descriptive 
term (i.e., submillisievert) for our study protocol but more importantly have also 
reported more meaningful radiation dose parameters (DLP, CTDIvol, effective diameter, 
SSDE).  
Our study has some limitations. First, the screening setting was only simulated 
evaluating CTs obtained for other clinical questions. We are aware, that inclusion 
criteria for lung cancer screening might be different, however, the discrepancy of 
pulmonary findings (i.e. nodule measurement/nodule classification) should not be 










limitations of in vivo studies on pulmonary nodule detection performance because no 
gold standard is available, however as our study focuses on the effect of interobserver 
variability and its impact on management we feel that no reference standard is 
required. Third, we did not reconstruct CT images with filtered back projection or 
varying strength levels of ADMIRE to test for its potential influence on nodule 
classification. Fourth, our readers were not trained for CT lung cancer screening. 
Further studies may assess whether a pre- and/or interim-screening training of 
radiologists can improve interreader agreement among different readers. Fifth, it may 
be regarded as a limitation that we used a somewhat simplified nodule classification 
system, given that our readers are not currently using any established guideline due to 
a lack of lung cancer screening in our country. However, we have added the readout 
spreadsheet from our study as supplementary material and further encourage future 
studies to assess nodule classification variability using other screening guidelines. 
Sixth, we did not use semi-/automated volume assessment and test its impact on 
measurement agreement as well as accuracy of lesion classification. Finally, we did 
not evaluate nodule structure (e.g., margins, density, solid/subsolid type) and test 
whether these differences may affect nodule classification. This should be elucidated 












In conclusion, our study showed a substantial interobserver variability for the 
classification of submillisievert CT for lung cancer screening, notably also among 
experienced radiologists. This highlights the importance for careful standardisation of 
screening programs with the objective of harmonizing efforts of involved radiologists 
across different institutions by defining and assuring quality standards. In addition, 
further studies are warranted to assess whether semi-automated detection, 
measurement and classification of pulmonary lesions may reduce the disagreement 
amongst readers. 
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Figure 1: Nodule classification as assessed by the six readers. The submillisievert CT 
scans were rated as either no nodule present = N1; clearly benign nodule containing 
fat (a) or calcification (b) = N2; any other nodule < 5 mm = N3; nodules between 5 – 
10 mm (d) = I; or nodules > 10 mm (e, f) = P. These findings were further subdivided 
in “negative findings” (N1, N2, N3) where no further action is needed and indeterminate 
findings (I) as well as positive findings (P).  
 













Figure 3: Frequency distribution of different nodule classification among the six 
readers. Study CT scans were classified as: No nodule present, benign nodules 
present (e.g., containing calcium or fat), any other nodule measuring < 5 mm, any other 
nodule measuring between 5 – 10 mm (indeterminate) and any nodule measuring > 
10 mm (positive). 











Figure 4: Reader results illustrating positive vs. non positive ratings (A) as well as 











Figure 5: Illustration of the most frequent reasons of disagreement among the six 
readers including nodule detection, nodule measurement, identification of different 
target lesion, and nodule classification.  In row 1, five out of six readers rated the scan 
as indeterminate (I), while the radiologist with 1y of experience rated the scan as 
Positive (P) due to different nodule measurement (range 5 - 12 mm). The reader with 
10y of experience has chosen a different target leasion, however this did not lead to a 
different classification ot the CT. In row 2, the reader with 1y of experience has chosen 
a different target lesion which led to different classification ot the CT (N3 vs. I). In row 










classification of the CT due to different nodule measurement (range 9 - 12 mm). In row 
4, four out of six readers rated the scan as Positive (P) due to a nodule > 10 mm 
adjacant to the descending aorta, while the remaining two readers rated the scan as 
Negative (N). This was due to missed nodule detection, potentially due to its close 
position to the descending aorta. In row 5, four out of six readers rated the scan as 
Positive (P) due to a nodule > 10 mm in the left lower lobe, while the reader with 15y 
of experience rated the scan as N2 and suggested the nodule was calcified. The reader 
with 1y of experience has chosen a different target lesion which led to different 
classification ot the CT the other readers. 
 
Number of years of experience (y). 
 





















Table 1 Nodule classification as assessed by the six readers. 
Category Features Screening result Code 
No nodule  Negative N1 




Nodules < 5 mm  Negative N3 
Nodules 5 - 10 mm  Indeterminate I 












Table 2 Interreader agreement for nodule classification. 
Reader Agreement Kappa p-value 
Overall 0.454 0.001 
Experienceda 0.404 0.001 
Unexperiencedb 0.544 0.001 
Reader 15y vs.   
 Reader 1y 0.448 0.001 
 Reader 2y 0.484 0.001 
 Reader 4y 0.513 0.001 
 Reader 9y 0.401 0.001 
 Reader 10y 0.360 0.001 
Reader 10y vs.   
 Reader 1y 0.447 0.001 
 Reader 2y 0.316 0.001 
 Reader 4y 0.377 0.001 
 Reader 9y 0.450 0.001 
Reader 9y vs.   
 Reader 1y 0.440 0.001 
 Reader 2y 0.513 0.001 
 Reader 4y 0.423 0.001 
Reader 4y vs.   
 Reader 1y 0.543 0.001 
 Reader 2y 0.540 0.001 
Reader 2y vs.   
 Reader 1y 0.550 0.001 
Number of years of experience (y), versus (vs.) 
a i.e., readers with 9, 10, and 15 years of experience 












Table 3 Absolute nodule classification per reader. No nodule present (N1), nodule of 
any size with calcium content (N2/C), nodule of any size with fat content (N2/F), any 
other nodule measuring ≤ 4 mm (N3), any other nodule measuring ≥ 5 mm and ≤ 10 





Reader 9y Reader 4y Reader 2y Reader 1y 
N1 23 44 35 24 25 39 
N2/C 8 4 7 13 4 9 
N2/F 2 0 0 0 0 0 
N3 32 17 20 13 25 11 
I 22 19 17 34 30 27 
P 13 16 21 16 16 14 












Table 4 Differences in nodule measurement by groups. 
Nodule size Mean, mm SD Mean range, mm 
Nodules < 5 mm 3.4 1.0 2.4 
Nodules 5 - 10 mm 7.1 2.6 5.2 
Nodules > 10 mm 19.7 9.2 6.4 












Table 5 Reasons for disagreement among all six readers in the study patients (n = 
100) 
Reason for disagreement Number of cases 
overall 
n = 155 
Number of cases were 
disagreement led to 
different managementa 
n = 77 
Nodule detection 45 (29%) 21 (27%) 
Nodule measurement 44 (28%) 23 (30%) 
Different target lesion 40 (26%) 21 (27%) 
Nodule classification 26 (17%)b 12 (16%)c 
Data are presented as n (%) 
a i.e., leading to a shift from a positive/indeterminate to a negative screening results and vice-versa 
b including identification of calcification (n = 24) and fat (n = 2) 
c including identification of calcification (n = 10) and fat (n = 2) 
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